ITMCTR2000003785尚未招募1 期
Standardized research and clinical efficacy evaluation of treatment of interstitial lung disease based on lung-collateral theory
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 80（—）
- 性别
- All
入选标准
- •1. Meet the western medicine diagnosis of the disease;
- •2. Meet the TCM diagnosis and syndrome differentiation standards of this disease;
- •3. The patient voluntarily accepted the treatment and signed the informed consent.
排除标准
- •1. Age> 80 years old;
- •2. Combined with tuberculosis, fungus, tumor, etc. and other primary lung diseases;
- •3. Patients with severe complications of other diseases such as cardiovascular, urinary, digestive, hematopoietic, endocrine and metabolic systems, liver and kidney insufficiency, and mental illness;
- •4. Pregnant or lactating women and those who are known to be allergic to the components of this medicine;
- •5. Those who fail to use the prescribed drugs and follow the doctor's advice, cannot judge the curative effect or whose clinical data is incomplete and affect the judgment;
- •6. Participating in other drug clinical trials.
研究者
相似试验
尚未招募
2 期
Drakshathi chooram for Pandu noi anaemia A pilot studyCTRI/2022/02/040567ational institute ofsiddha
尚未招募
3 期
therapeutic effectiveness of Siddha formulation Thanneervittan Nei in the management of Moothirakiricharam (Urinary Tract Infection) â?? A Pilot studyCTRI/2022/03/040777ational institute of siddha
尚未招募
1 期
Research on standardization and clinical evaluation of Traditional Chinese Medicine press needle combined with auricular point pressing to prevent and control myopia in children and adolescentsITMCTR2100005080Eye Hospital China Academy of Chinese Medical Science
招募中
3 期
The comparison between short and long infusion of Ampicillin-Sulbactam in patients with sepsis and severe sepsis in the intensive care unit of Namazee and shahid Rajaee hospital in Shiraz.Condition 1: Severe Sepsis. Condition 2: Sepsis.Severe sepsisSepsis, unspecified organismR65.2A41.9IRCT20190425043368N1Shiraz University of Medical Sciences136
已完成
不适用
Clinical Research on the efficacy evaluation and the biomarker of nivolumab to an advance malignant melanomamalignant melanomaJPRN-UMIN000016608Public Health Research Foundation128